ABCB6 |
Q9NP58
|
ATP binding cassette subfamily B member 6 (Langereis blood group)
|
Transporter
|
8.6E-19 |
0.431 |
0.885 |
ACTB |
P60709
|
actin beta
|
Cellular structure
|
0.99 |
0.325 |
0.923 |
AKT1 |
P31749
|
AKT serine/threonine kinase 1
|
Kinase
|
0.98 |
0.311 |
0.962 |
ALK |
Q9UM73
|
ALK receptor tyrosine kinase
|
Kinase
|
3.2E-06 |
0.396 |
0.846 |
APC |
P25054
|
APC regulator of WNT signaling pathway
|
|
1.00 |
0.373 |
0.962 |
APOA1 |
P02647
|
apolipoprotein A1
|
|
5.5E-04 |
0.429 |
0.885 |
APOE |
P02649
|
apolipoprotein E
|
|
1.9E-03 |
0.338 |
0.962 |
AR |
P10275
|
androgen receptor
|
Nuclear receptor
|
0.99 |
0.351 |
0.846 |
ATM |
Q13315
|
ATM serine/threonine kinase
|
Kinase
|
5.6E-47 |
0.374 |
0.885 |
BAAT |
Q14032
|
bile acid-CoA:amino acid N-acyltransferase
|
|
7.9E-08 |
0.578 |
0.654 |
BAX |
Q07812
|
BCL2 associated X, apoptosis regulator
|
Signaling
|
0.32 |
0.417 |
0.885 |
BCL2 |
P10415
|
BCL2 apoptosis regulator
|
Signaling
|
0.56 |
0.291 |
0.885 |
BGN |
P21810
|
biglycan
|
|
0.45 |
0.484 |
0.808 |
BMI1 |
P35226
|
BMI1 proto-oncogene, polycomb ring finger
|
|
0.94 |
0.448 |
0.808 |
BMPR1A |
P36894
|
bone morphogenetic protein receptor type 1A
|
Kinase
|
0.90 |
0.522 |
0.731 |
BRAF |
P15056
|
B-Raf proto-oncogene, serine/threonine kinase
|
Kinase
|
1.00 |
0.319 |
0.846 |
BRCA1 |
P38398
|
BRCA1 DNA repair associated
|
Enzyme
|
9.2E-29 |
0.367 |
0.923 |
BRCA2 |
P51587
|
BRCA2 DNA repair associated
|
Nucleic acid binding
|
2.4E-25 |
0.379 |
0.846 |
BTRC |
Q9Y297
|
beta-transducin repeat containing E3 ubiquitin protein ligase
|
|
1.2E-02 |
0.601 |
0.731 |
CBLL2 |
Q8N7E2
|
Cbl proto-oncogene like 2
|
Enzyme
|
|
0.476 |
0.808 |
CCDC6 |
Q16204
|
coiled-coil domain containing 6
|
|
0.58 |
0.517 |
0.808 |
CCL2 |
P13500
|
C-C motif chemokine ligand 2
|
Signaling
|
0.61 |
0.321 |
0.962 |
CCND1 |
P24385
|
cyclin D1
|
Enzyme modulator
|
0.89 |
0.344 |
0.923 |
CD24 |
P25063
|
CD24 molecule
|
|
|
0.472 |
0.769 |
CD44 |
P16070
|
CD44 molecule (Indian blood group)
|
|
2.4E-07 |
0.363 |
0.962 |